Where I see patients (1)
Selected research
-
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
Blood
-
Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS.
Blood
-
Erratum: Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology